LH

Labcorp Holdings Inc.

Healthcare · $25.3B market cap

Verdict

Share price

$308.49

close of Oct 3, 2026

Fair value

$280.03

Sticker Price

Payback Price

$112.01

buy price

Overpriced

LH is Overpriced: at $308.49 it trades 10% above its fair value of $280.03. Its buy price (Payback Price) is $112.01, 64% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth4.8% a year✗
Equity per share growth13.0% a year✓
Sales growth7.4% a year✗
Free cash flow growth5.0% a year✗
Return on invested capital5.3%✗

Follow LH

Get notified when it reaches its buy price of $112.01. Free.

Create a free account

Superinvestors

3 of the investors we track hold LH. In Q2 2026, 1 trimmed and 1 sold out. Who we track

Moves in Q2 2026

Trimmed: Jensen Investment Management

Sold out: Lee Ainslie

Insider activity

Since Jul 1, 2026: no open-market purchases, 7 sales worth $3.3M and 9 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works